Nomura Holdings’s Lexicon Pharmaceuticals LXRX Stock Holding History

Nomura Holdings’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-212,620	Closed	-$410K	–	1849
2022 Q2	$410K	Sell	212,620 -421,018	-66%	-$803K	﹤0.01%	1160
2022 Q1	$1.41M	Buy	633,638 +55,258	+10%	+$153K	﹤0.01%	995
2021 Q4	$2.28M	Sell	578,380 -87,366	-13%	-$424K	0.01%	966
2021 Q3	$3.21M	Sell	665,746 -253,021	-28%	-$1.04M	0.01%	775
2021 Q2	$4.25M	Hold	918,767	–	–	0.01%	623
2021 Q1	$5.4M	Buy	+918,767	New	+$6.36M	0.01%	525

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Nomura Holdings's LXRX Position: Q3 2022 in Review

Nomura Holdings sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2022, closing a stake of 212,620 shares — an estimated $410K sold.

Nomura Holdings first reported a position in LXRX in Q1 2021 and held it in 6 quarters. The position peaked at $5.4M in Q1 2021. 98 funds tracked by Wall St. Rank hold LXRX as of Q3 2022.

Nomura Holdings reported no remaining Lexicon Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Nomura Holdings sold 212,620 Lexicon Pharmaceuticals shares in Q3 2022, an estimated $410K.
Nomura Holdings first reported a position in Lexicon Pharmaceuticals in Q1 2021 and held it in 6 quarters.
Nomura Holdings's Lexicon Pharmaceuticals position peaked at $5.4M in Q1 2021.
98 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2022.

Based on Nomura Holdings's 13F filing for Q3 2022, filed 15 Nov 2022.